Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Margaret L MacMillanNancy A Kernan

Abstract

The National Marrow Donor Program (NMDP) has facilitated unrelated donor hematopoietic cell transplants for more than 20 years. In this time period, there have been many changes in clinical practice, including improvements in HLA typing and supportive care, and changes in the source of stem cells. Availability of banked unrelated donor cord blood (incorporated into the NMDP registry in 2000) as a source of stem cells has become an important option for children with leukemia, offering the advantages of immediate availability for children with high-risk disease, the need for a lesser degree of HLA match, and expanding access for those with infrequent HLA haplotypes. Overall survival (OS) in children with acute leukemia transplanted with unrelated donor bone marrow (BM) is markedly better in more recent years, largely attributable to less treatment-related mortality (TRM). Within this cohort, 2-year survival was markedly better for patients with acute lymphoblastic leukemia (ALL) in first complete response (CR1) (74%) versus second complete response (CR2) (62%) or more advanced disease (33%). Similar findings are observed with patients with AML, suggesting earlier referral to bone marrow transplant (BMT) is optimal for survival. N...Continue Reading

References

Apr 20, 2002·Blood·Nancy BuninUNKNOWN National Marrow Donor Program Working Group
Oct 22, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Carolyn Katovich HurleyDennis L Confer
Dec 31, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary EapenJohn E Wagner
Apr 24, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·John MooreAnthony Dodds
Nov 21, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mary EapenClaudio Anasetti
Mar 1, 2008·British Journal of Haematology·Evelio D Perez-AlbuerneNaynesh Kamani
Jun 11, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel WeisdorfJohn Klein

❮ Previous
Next ❯

Citations

May 7, 2010·Current Hematologic Malignancy Reports·Michael R Verneris, Michael J Burke
Jun 2, 2010·Haematologica·Jacopo Peccatori, Fabio Ciceri
Dec 3, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Navneet S MajhailJohn E Levine
Sep 9, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christina K UllrichSusan K Parsons
Jun 2, 2015·Human Immunology·Wyatt C NelsonDaniel E Geraghty
Aug 18, 2009·British Journal of Haematology·Derwood PamphilonSimon Stanworth
Mar 18, 2016·Journal of Pediatric Psychology·Danielle M GraefValerie McLaughlin Crabtree
Jan 14, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael A PulsipherChing-Hon Pui
Dec 14, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel WeisdorfJeffrey Miller
Apr 2, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sarah J KizilbashAngela R Smith
Aug 8, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mohamed A Kharfan-DabajaAmbuj Kumar
Jan 18, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christopher C DvorakAlexandra Filipovich
Jan 18, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul A CarpenterStella M Davies
Jun 15, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Koji KatoUNKNOWN Japan Cord Blood Bank Network
May 5, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Navneet S MajhailJ Douglas Rizzo
Feb 10, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Elizabeth A MurphyNavneet S Mahjail
May 24, 2016·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Lucilla LecchiMaurizio Marconi
Mar 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christina PetersThomas Klingebiel
Oct 9, 2018·Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation·Amir Ali HamidiehArdeshir Ghavamzadeh
Jun 17, 2014·Bone Marrow Transplantation·M A PulsipherK R Schultz
Jan 18, 2011·Hematology·Stella M Davies, Parinda A Mehta
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert M DeanMichael R Bishop
Dec 10, 2019·Current Opinion in Pediatrics·Caitlin W Elgarten, Richard Aplenc
Apr 7, 2020·American Journal of Audiology·Maeve SalangerAndrew Dergan
Jun 2, 2020·Journal of Speech, Language, and Hearing Research : JSLHR·Ilze OosthuizenDe Wet Swanepoel
Feb 26, 2020·Pediatric Emergency Care·Kelly R BergmannRonald A Furnival

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.